GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Pharmaceutical Co Ltd (SHSE:600713) » Definitions » Other Long Term Assets

Nanjing Pharmaceutical Co (SHSE:600713) Other Long Term Assets : ¥920 Mil (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Nanjing Pharmaceutical Co Other Long Term Assets?

Nanjing Pharmaceutical Co's other long-term assets for the quarter that ended in Mar. 2024 was ¥920 Mil.

Nanjing Pharmaceutical Co's quarterly other long-term assets declined from Sep. 2023 (¥602 Mil) to Dec. 2023 (¥599 Mil) but then increased from Dec. 2023 (¥599 Mil) to Mar. 2024 (¥920 Mil).

Nanjing Pharmaceutical Co's annual other long-term assets declined from Dec. 2021 (¥595 Mil) to Dec. 2022 (¥553 Mil) but then increased from Dec. 2022 (¥553 Mil) to Dec. 2023 (¥599 Mil).

Nanjing Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Nanjing Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Pharmaceutical Co Other Long Term Assets Chart

Nanjing Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 710.18 694.09 595.44 552.96 599.38

Nanjing Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 587.94 572.84 602.30 599.38 920.31

Nanjing Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Nanjing Pharmaceutical Co (SHSE:600713) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Pharmaceutical Co Ltd (SHSE:600713) » Definitions » Other Long Term Assets
Comparable Companies
SZSE:301096 SZSE:300109 SZSE:000411 SZSE:301507 SHSE:600666 SZSE:002198 SHSE:600613 SZSE:300006 SZSE:301281 SZSE:001367 LLY JNJ MRK ABBV LSE:AZN XSWX:NOVN XSWX:ROG AMGN PFE XPAR:SAN
Traded in Other Exchanges
N/A
Address
No. 486 Zhongshan East Road, Nanjing, Jiangsu, CHN, 210002
Website
http://www.guangyuyuan.com
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
Executives
Xiao Hong senior management
Peng Yu Ping senior management
She Ping Supervisors
Jiang Xiao Jun senior management
Teng Xue Wu senior management
Zhou Jian Jun senior management
Li Yi Director
Huang Yan Li Supervisors
Tang Jian Zhong senior management
Zhang Yan Hui senior management
Zhou Yao Ping Director
Wang Hui Qing senior management
He Jin Geng senior management
Ding Feng Jun Director
Liang Yu Tang Director

Nanjing Pharmaceutical Co (SHSE:600713) Headlines

No Headlines